Cardiopulmonary effects of dexmedetomidine in sevoflurane-anesthetized sheep with and without nitric oxide inhalation

American Journal of Veterinary Research

Volumn 66, Issue 9, 2005, Pages 1496-1502

  Kästner, Sabine B R ^a   Kull, Susanne ^a   Kutter, Annette P N ^a   Boller, Jolanda ^a   Bettschart Wolfensberger, Regula ^a   Huhtinen, Mirja K ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ORION CORPORATION   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; NITRIC OXIDE; SEVOFLURANE;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL OXYGEN TENSION; ARTICLE; BOLUS INJECTION; BREATHING MECHANICS; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENERAL ANESTHESIA; HEART OUTPUT; LUNG DEAD SPACE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PULMONARY HYPERTENSION; SHEEP; SHUNTING; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; TISSUE OXYGENATION;

ADRENERGIC ALPHA-AGONISTS; AIRWAY RESISTANCE; ANESTHETICS, INHALATION; ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; CROSS-OVER STUDIES; DEXMEDETOMIDINE; HEART RATE; HYPERTENSION, PULMONARY; LUNG COMPLIANCE; METHYL ETHERS; NITRIC OXIDE; RESPIRATORY MECHANICS; SHEEP; SHEEP DISEASES; STROKE VOLUME; TIME FACTORS;

ANIMALIA; OVIS ARIES;

EID: 27744448947     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.1496     Document Type: Article

References (50)

1. Uggla A, Lindquist A. Acute pulmonary oedema as an adverse reaction to the use of xylazine in sheep. Vet Rec 1983;113:42.
2. Doherty TJ, Pascoe PJ, McDonell WN, et al. Cardiopulmonary effects of xylazine and yohimbine in laterally recumbent sheep. Can J Vet Res 1986;50:517-521.
3. Nolan A, Livingston A, Waterman A. The effects of alpha 2 adrenoceptor agonists on airway pressure in anaesthetized sheep. J Vet Pharmacol Ther 1986;9:157-163.
4. Eisenach JG. Intravenous clonidine produces hypoxemia by a peripheral alpha 2 adrenergic mechanism. J Pharmacol Exp Ther 1988;244:247-252.
5. Celly CS, McDonell WN, Young SS, et al. The comparative hypoxaemic effect of four alpha 2 adrenoceptor agonists (xylazine, romifidine, detomidine and medetomidine) in sheep. J Vet Pharmacol Ther 1997;20:464-471.
6. Celly CS, McDonell WN, Black WD, et al. Cardiopulmonary effects of clonidine, diazepam and the peripheral alpha2 adrenoceptor agonist ST-91 in conscious sheep. J Vet Pharmacol Ther 1997;20:472-478.
7. Kästner SBR, Keller K, Rechenberg BV, et al. Comparison of medetomidine and dexmedetomidine as premedication in isoflurane anaesthesia for total hip replacement in domestic sheep. J Vet Med A Physiol Pathol Clin Med 2001;48:231-241.
8. Papazoglou L, Raptopoulos D, Kokolis N. Increased airway pressure in response to xylazine is inhibited by both atipamezole and atropine in sheep. Zentralbl Veterinarmed [A] 1994;41:568-572.
9. Papazoglou L, Raptopoulos D, Kounenis G. The effect of xylazine on the isolated sheep trachea. J Vet Pharmacol Ther 1995;18:216-219.
10. Raptopoulos D, Weaver BM, Papanastassopoulos M, et al. The effect of xylazine on plasma thromboxane B2 concentration in sheep. J Vet Pharmacol Ther 1995;18:438-441.
11. Papazoglou L, Raptopoulos D, Kritsepi M, et al. Effects of alpha 2 adrenergic drugs on blood platelets in sheep. J Vet Anaesth 1993;20:30-31.
12. 2-adrenergic receptor agonists. Am J Vet Res 1999; 60:154-161.
13. Bacon PJ, Jones JG, Taylor P, et al. Impairment of gas exchange due to alveolar oedema during xylazine sedation in sheep; absence of a free radical mediated inflammatory mechanism. Res Vet Sci 1998;65:71-75.
14. 2-adrenoceptor agonist. Eur J Pharmacol 1988;150:9-14.
15. Virtanen R. Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand 1989;85:29-37.
16. Anggard E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994;343:1199-1206.
17. Gibson Q, Roughton F. The kinetics of equilibria of the reactions of nitric oxide with sheep hemoglobin. J Physiol (Lond) 1957;136:507-526.
18. Rimar S, Gillis C. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993;88:2884-2887.
19. Hampl V, Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 2000;80:1337-1372.
20. Bernasconi A, Beghetti M. Inhaled nitric oxide applications in paediatric practice. Images Paediatr Cardiol 2002;10:4-29.
21. Roberts JD, Zapol WR. Inhaled nitric oxide. Semin Perinatol 2000;24:55-58.
22. Sustronck B, Loon GV, Deprez P, et al. Effect of inhaled nitric oxide on the hypoxic pulmonary vasoconstrictor response in anaesthetised calves. Res Vet Sci 1997;63:193-197.
23. Lester GD, DeMarco VG, Norman WN. Effect of inhaled nitric oxide on experimentally induced pulmonary hypertension in neonatal foals. Am J Vet Res 1999;60:1207-1212.
24. Frostell C, Fratacci M, Wain J, et al. Inhaled nitric oxide: a selective vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-2047.
25. Fratacci M, Frostell C, Chen T, et al. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anaesthesiology 1991;75:990-999.
26. Caulkett NA, Duke T, Cribb PH. Cardiopulmonary effects of medetomidine-ketamine in domestic sheep (Ovis ovis) maintained in sternal recumbency. J Zoo Wildl Med 1996;27:217-226.
27. Kenny D, Pelc L, Brooks H, et al. Calcium channel modulation of alpha1 and alpha2 adrenergic pressor responses in conscious and anaesthetized dogs. Anesthesiology 1990;72:874-881.
28. Talke P, Lobo E, Brown R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology 2003;99:65-70.
29. Ishibe Y, Gui X, Uno H, et al. Effect of sevoflurane on hypoxic pulmonary vasoconstriction in the perfused rabbit lung. Anesthesiology 1993;79:1348-1353.
30. Celly CS, McDonell WN, Black WD. Cardiopulmonary effects of the alpha2 adrenoceptor agonists medetomidine and ST-91 in anesthetized sheep. J Pharmacol Exp Ther 1999;289:712-720.
31. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Anaesthesia 1999;54:146-165.
32. Docherty JR, McGrath JC. A comparison of pre- and postjunctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Naunyn Schmiedebergs Arch Pharmacol 1980;312:107-116.
33. Link R, Desai K, Hein L. Cardiovascular regulation in mice lacking alpha-adrenergic subtypes b and c. Science 1996; 273:803-805.
34. Aantaa R. Alpha-2 adrenoceptor agonists in human anaesthesiology and intensive care, in Proceedings. 7th World Cong Vet Anaesth 2000;13-16.
35. Timmermans P, Dejonge A, VanZwieten P. Comparative quantitative studies on central and peripheral alpha adrenoceptors. Chest 1983;83(suppl):354-356.
36. Ranheim B, Arnemo JM, Stuen S, et al. Medetomidine and atipamezole in sheep: disposition and clinical effects. J Vet Pharmacol Ther 2000;23:401-404.
37. Muge DK, Chambers JP, Livingston A. Single dose pharmacokinetics of medetomidine in sheep. J Vet Pharmacol Ther 1996; 19:109-112.
38. Bloor B, Ward D, Belleville J, et al. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992;77:1134-1142.
39. Bryant CE, Clarke KW, Thompson J. Cardiopulmonary effects of medetomidine in sheep and ponies. Res Vet Sci 1996;60:267-271.
40. Schmeling W, Kampine J, Roerig D, et al. The effects of stereoisomers of the alpha2-agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology 1991; 75:499-511.
41. Bryant CE, Thompson J, Clarke KW. Characterisation of the cardiovascular pharmacology of medetomidine in the horse and sheep. Res Vet Sci 1998;65:149-154.
42. Flacke WE, Flacke JW, Bloor BC, et al. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiothorac Vasc Anesth 1993;7:41-49.
43. Ebert T, Hall J, Barney J, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382-394.
44. Lawrence CJ, Prinzen FW, DeLange S. Hemodynamic and coronary vascular effects of dexmedetomidine in the anesthetized goat. Acta Anaesth Scand 1997;41:830-836.
45. Talke PO, Traber DL, Richardson CA, et al. The effect of alpha2 agonist-induced sedation and its reversal with an alpha2 antagonist on organ blood flow in sheep. Anesth Analg 2000; 90:1060-1066.
46. Booke M, Bradford D, Hinder F, et al. Effects of inhaled nitric oxide and nebulized prostacyclin on hypoxic pulmonary vasoconstriction in anesthetized sheep. Crit Care Med 1996;24:1841-1848.
47. Ichinose F, Roberts JD Jr, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator. Current uses and therapeutic potential. Circulation 2004;109:3106-3111.
48. Piascik MT, Soltis E, Piascik MM, et al. Alpha-adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates. Pharmacol Ther 1996;72:215-241.
49. Högman M, Frostell C, Arnberg H, et al. Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit. Eur Respir J 1993;6:177-180.
50. Vanhoutte P. Epithelium derived relaxing factor(s) and bronchial reactivity. Am Rev Respir Dis 1988;138:S24-S30.